EA200601214A1 - Композиции пробиотической таблетки - Google Patents

Композиции пробиотической таблетки

Info

Publication number
EA200601214A1
EA200601214A1 EA200601214A EA200601214A EA200601214A1 EA 200601214 A1 EA200601214 A1 EA 200601214A1 EA 200601214 A EA200601214 A EA 200601214A EA 200601214 A EA200601214 A EA 200601214A EA 200601214 A1 EA200601214 A1 EA 200601214A1
Authority
EA
Eurasian Patent Office
Prior art keywords
zone
organism
micro
probiotic
probiotic micro
Prior art date
Application number
EA200601214A
Other languages
English (en)
Other versions
EA011321B1 (ru
Inventor
Кристиан Лунн Хенриксен
Хелена Матильда Мортенсен
Марианна Виннинг
Original Assignee
Ферросан А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30776514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601214(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ферросан А/С filed Critical Ферросан А/С
Publication of EA200601214A1 publication Critical patent/EA200601214A1/ru
Publication of EA011321B1 publication Critical patent/EA011321B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Пробиотическая таблетка, содержащая пробиотический микроорганизм и другие активные в питательном отношении ингредиенты в двух зонах, причем первая из этих зон содержит указанный пробиотический микроорганизм, а вторая зона содержит по меньшей мере один указанный другой активный ингредиент, такой как железо, другие минеральные соединения и витамин В6, удерживаемый отдельно от пробиотического микроорганизма указанной первой зоны, причем активность воды в указанной содержащей пробиотический микроорганизм первой зоне равна не более чем 0,2, и содержание воды указанной таблетки составляет не менее 3 мас.%. Получают хорошую жизнеспособность этих микроорганизмов, несмотря на относительно высокое общее содержание влаги.
EA200601214A 2003-12-24 2004-12-21 Пробиотическая таблетка EA011321B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0330009.2A GB0330009D0 (en) 2003-12-24 2003-12-24 Probiotic tablet formulations
PCT/EP2004/014545 WO2005063200A2 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations

Publications (2)

Publication Number Publication Date
EA200601214A1 true EA200601214A1 (ru) 2006-12-29
EA011321B1 EA011321B1 (ru) 2009-02-27

Family

ID=30776514

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601214A EA011321B1 (ru) 2003-12-24 2004-12-21 Пробиотическая таблетка

Country Status (15)

Country Link
US (2) US10172793B2 (ru)
EP (1) EP1699474B2 (ru)
CN (1) CN1913905B (ru)
AT (1) ATE453397T1 (ru)
AU (1) AU2004308632B2 (ru)
CA (1) CA2551581A1 (ru)
DE (1) DE602004024924D1 (ru)
DK (1) DK1699474T4 (ru)
EA (1) EA011321B1 (ru)
ES (1) ES2336680T5 (ru)
GB (1) GB0330009D0 (ru)
NO (1) NO340908B1 (ru)
PL (1) PL1699474T5 (ru)
UA (1) UA87296C2 (ru)
WO (1) WO2005063200A2 (ru)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1880001B1 (en) 2005-05-31 2011-06-08 The Iams Company Feline probiotic lactobacilli
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
PT1928426E (pt) * 2005-09-29 2014-12-02 Merck Patent Gmbh Processo para a estabilização de formas farmacêuticas que contêm microrganismos
AU2012244263B2 (en) * 2005-10-12 2015-09-17 Genencor International, Inc. Stable, durable granules with active agents
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8524304B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US20080241805A1 (en) 2006-08-31 2008-10-02 Q-Track Corporation System and method for simulated dosimetry using a real time locating system
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
US9078824B2 (en) * 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN101259278B (zh) * 2008-04-21 2010-06-02 黄芝芳 一种含抑菌剂的多种水溶性维生素的药物组合物及其制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2210593A3 (en) * 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR101102364B1 (ko) * 2009-09-18 2012-01-03 한림제약(주) 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
DE102011122250A1 (de) * 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20170005093A (ko) 2014-05-12 2017-01-11 바이오위시 테크놀로지스, 인크. 인간 건강 및 영양 향상을 위한 조성물 및 방법
BR112016031000B1 (pt) 2014-07-01 2022-01-25 Probi USA, Inc. Forma de dosagem em camadas e método para fazer a mesma
CN104489646B (zh) * 2014-11-19 2016-08-31 李雅君 一种果蔬益生菌片剂及其制备方法
CA2985729C (en) 2015-05-11 2023-05-09 Mybiotics Pharma Ltd Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
JP7017849B2 (ja) * 2015-09-11 2022-02-09 シムライズ アーゲー 経口投与剤形
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
CN108778300A (zh) * 2015-10-07 2018-11-09 拜福丹公司 益生菌制剂
MY191729A (en) * 2015-10-16 2022-07-13 Novex Science Pte Ltd Stable composition of vitamin c and zinc tablet
CN105962376A (zh) * 2016-04-28 2016-09-28 内蒙古乌审召生态产业发展有限公司 一种具有层结构的螺旋藻片及其制备方法
AU2017271491A1 (en) 2016-05-25 2018-12-13 Mybiotics Pharma Ltd. Composition and methods for microbiota therapy
MX2019004583A (es) * 2016-11-10 2019-08-12 Soc Des Produits Nestle S A Star Composicion en forma de polvo que comprende hierro y bacterias probioticas.
IT201700011337A1 (it) * 2017-02-02 2018-08-02 S I I T S R L Servizio Int Imballaggi Termosaldanti Compressa multistrato per la somministrazione di magnesio
CN107821753A (zh) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 一种宠物用益生菌颗粒制剂及其制备方法
WO2019101832A1 (en) * 2017-11-27 2019-05-31 Dsm Ip Assets B.V. Freeze-dried multiparticulate solid dosage form
WO2019232026A1 (en) 2018-05-29 2019-12-05 BiOWiSH Technologies, Inc. Compositions and methods for improving survivability of aquatic animals
US11247944B2 (en) 2019-04-12 2022-02-15 Jeffrey Hanson Robbins Potassium citrate mixture formed from a dry fertilizer and methods thereof
US11254619B2 (en) 2019-04-12 2022-02-22 Jeffrey Hanson Robbins Dry composition including effervescent agents, biostimulant, and plant nutrient
BR112021020606A2 (pt) * 2019-04-15 2021-12-07 Fund Clinic Per A La Recerca Biomedica Composição de microbiota fecal viva estável a longo prazo
CN110934751B (zh) * 2019-12-31 2022-09-02 成都三勒浆药业集团四川华美制药有限公司 一种用于口腔健康的双层口含片及其制备方法
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
DE3369829D1 (en) † 1983-02-18 1987-04-02 Nabisco Brands Inc Canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4956295A (en) † 1984-05-21 1990-09-11 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
JPH0780754B2 (ja) * 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5310555A (en) † 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5885481A (en) 1993-07-16 1999-03-23 Amoco Corporation Efficiency oxygen-scavenging compositions and articles
FR2716341B1 (fr) † 1994-02-23 1996-05-10 Gervais Danone Sa Composition alimentaire comportant un biscuit ou une coque de chocolat et un fourrage à base de produit laitier, fermenté ou non .
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
SE513815C2 (sv) 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet
US5774056A (en) 1996-05-30 1998-06-30 Engineered Products Co. Gauge for monitoring air filters
US6083585A (en) 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
GB2323532B (en) * 1997-03-27 2001-08-22 Bakulesh Mafatlal Khamar Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
EP0931543B1 (de) * 1997-12-19 2002-03-20 MERCK PATENT GmbH Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
US6169387B1 (en) 1997-12-22 2001-01-02 Lifecor, Inc. Battery management apparatus for portable electronic devices
PT956858E (pt) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
DE19819475A1 (de) † 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
EP1102595A2 (en) 1998-08-07 2001-05-30 Ganeden Biotech, Inc. Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
DE69932030T2 (de) † 1999-04-09 2007-01-04 Société des Produits Nestlé S.A. Roher belegter Pizzateig
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
SE515310C2 (sv) 1999-11-25 2001-07-09 Wasa Medicals Ab Tabletter innehållande mikroorganismer och förfarande för framställning därav
US6399114B2 (en) 2000-05-26 2002-06-04 C & D Foreman, Inc. Nutritional system for nervous system disorders
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
WO2003026687A1 (en) 2001-09-28 2003-04-03 Nutraceutix, Inc. Delivery system for biological component
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol Pharmazeutische Vertr Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
DE10206995B4 (de) † 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
EP1344458A1 (en) † 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
WO2003080813A2 (en) 2002-03-21 2003-10-02 Bifodan A/S Lactobacillus strains
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US9210945B2 (en) † 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
MX2012001754A (es) † 2009-08-13 2012-03-21 Kellog Co Aglutinante alimenticio de baja actividad de agua y metodos relacionados con el mismo.

Also Published As

Publication number Publication date
GB0330009D0 (en) 2004-01-28
ES2336680T5 (es) 2014-01-20
EA011321B1 (ru) 2009-02-27
EP1699474A2 (en) 2006-09-13
DE602004024924D1 (de) 2010-02-11
WO2005063200A2 (en) 2005-07-14
PL1699474T5 (pl) 2014-02-28
AU2004308632A1 (en) 2005-07-14
ES2336680T3 (es) 2010-04-15
PL1699474T3 (pl) 2010-06-30
US20070269515A1 (en) 2007-11-22
AU2004308632B2 (en) 2010-07-01
WO2005063200A3 (en) 2005-11-24
DK1699474T3 (da) 2010-04-12
UA87296C2 (en) 2009-07-10
US10172793B2 (en) 2019-01-08
CN1913905B (zh) 2010-09-08
NO20063410L (no) 2006-09-22
NO340908B1 (no) 2017-07-10
ATE453397T1 (de) 2010-01-15
DK1699474T4 (da) 2013-12-02
CN1913905A (zh) 2007-02-14
EP1699474B1 (en) 2009-12-30
US20190091145A1 (en) 2019-03-28
CA2551581A1 (en) 2005-07-14
EP1699474B2 (en) 2013-10-23

Similar Documents

Publication Publication Date Title
EA200601214A1 (ru) Композиции пробиотической таблетки
DE59706697D1 (de) Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
HUP0301939A2 (hu) Új probiotikumok hobbiállat-eledel kompozíciókhoz
DK0973413T3 (da) Levnedsmiddelformuleringer indeholdende lacto-N-neotetraose
DE60041357D1 (de) Extrakte aus pueraria mirifica sowie deren extraktion
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
TW200700074A (en) Inducer of t cell apoptosis
DE502005010277D1 (de) Teinen
NO20054765L (no) Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav
GB2443793B (en) Product, method of manufacture and use
ATE451110T1 (de) Zusammensetzung mit immunregulierenden wirkungen aus lactobacillus pentosus
MY140870A (en) Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein
FR2827774B1 (fr) Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
DE60115919D1 (de) Neuartige lactobacillus paracasei stämme
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
ATE285757T1 (de) Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten
RU2001113082A (ru) Состав для изготовления драже
Jinpeng Selenium and Kashin-Beck Disease
RU2003112420A (ru) Биопрепарат лечебно-профилактического действия при эндометритах животных
RU2005104618A (ru) Штамм bifidobacterium lactis 678, используемый в составе пищевых продуктов, заквасок, биологически активных добавок, лекарственных и косметических средств
RU2005104616A (ru) Штамм bifidobacterium lactis 672, используемый в составе пищевых продуктов, заквасок, биологически активных добавок, лекарственных и косметических средств
BG108251U (en) Probiotic food additive

Legal Events

Date Code Title Description
TC4A Change in name of a patent proprietor in a eurasian patent